Stay updated with breaking news from Malaria Venture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In today's Research Roundup for April 29, 2024, we highlight some of the most interesting reads in global health research and development from the past week.
Australia government announces funding for MMV, working towards malaria elimination in the Indo-Pacific region and beyond.
YONGIN, South Korea, April 25, 2024 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that the results of a clinical
miLab showed almost equivalent to WHO-certified first-degree microscopy experts: Sensitivity of 94.4%, Specificity of 98.1% African authority on malaria diagnosis said "miLab is a potential game changer in accelerating access to parasitological confirmation" YONGIN, South Korea, April 25, 2024 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that the results of a clinical performance...
Medicines for Malaria Venture (MMV) and Novartis announce positive data from their phase II/III CALINA study, demonstrating that a novel formulation of Coartem® developed for babies weighing less than 5kg with malaria has the required pharmacokinetic profile and therefore efficacy and safety.